Andrew Gesek's most recent trade in Petros Pharmaceuticals Inc was a trade of 75,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 11, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Petros Pharmaceuticals Inc | Andrew Gesek | President, Timm Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
Petros Pharmaceuticals Inc | Andrew Gesek | President, Timm Medical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 97 | 97 | - | - | Common Stock, par value $0.0001 per share |